NexgenRx Inc.
NEGXF
$0.20
$0.00351.78%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.94M | 2.87M | 3.08M | 2.50M | 2.42M |
| Total Other Revenue | 105.10K | 110.60K | 108.40K | 123.50K | 108.00K |
| Total Revenue | 3.05M | 2.99M | 3.18M | 2.63M | 2.53M |
| Cost of Revenue | 727.60K | 660.80K | 659.80K | 606.70K | 547.90K |
| Gross Profit | 2.32M | 2.32M | 2.52M | 2.02M | 1.98M |
| SG&A Expenses | 1.97M | 2.03M | 1.93M | 1.97M | 1.82M |
| Depreciation & Amortization | 227.10K | 235.50K | 236.50K | 234.20K | 240.10K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.93M | 2.92M | 2.83M | 2.81M | 2.61M |
| Operating Income | 123.00K | 61.80K | 355.70K | -185.30K | -84.20K |
| Income Before Tax | 92.70K | 6.60K | 324.90K | -215.80K | -113.40K |
| Income Tax Expenses | -16.80K | -16.70K | -17.00K | 69.10K | -15.90K |
| Earnings from Continuing Operations | 109.40K | 23.30K | 341.90K | -284.90K | -97.50K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 109.40K | 23.30K | 341.90K | -284.90K | -97.50K |
| EBIT | 123.00K | 61.80K | 355.70K | -185.30K | -84.20K |
| EBITDA | 350.10K | 297.30K | 579.30K | 37.40K | 155.90K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 71.08M | 70.92M | 70.92M | 70.53M | 70.53M |
| Average Diluted Shares Outstanding | 76.68M | 76.52M | 72.72M | 70.53M | 75.83M |
| Dividend Per Share | 0.00 | 0.00 | -- | 0.00 | 0.00 |
| Payout Ratio | 22.11% | 1,214.16% | 7.16% | -108.02% | -25.24% |
